Evaluation of optimal 5ASA dose in order to determine for keeping remission of patients with ulcerative colitis by colonoscopy using FICE (flexible spectral imaging color enhancement) system.
Phase of Trial: Phase IV
Latest Information Update: 04 Jan 2018
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 02 Jan 2018 Status changed from recruiting to completed.
- 06 Apr 2011 New trial record